203 related articles for article (PubMed ID: 31437118)
1. Comparison of antiproliferative effect of epigallocatechin gallate when loaded into cationic solid lipid nanoparticles against different cell lines.
Silva AM; Martins-Gomes C; Fangueiro JF; Andreani T; Souto EB
Pharm Dev Technol; 2019 Dec; 24(10):1243-1249. PubMed ID: 31437118
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of (-)-Epigallocatechin-3-gallate (EGCG)-loaded nanoparticles and their inhibitory effects on Human breast cancer MCF-7 cells.
Zeng L; Yan J; Luo L; Ma M; Zhu H
Sci Rep; 2017 Mar; 7():45521. PubMed ID: 28349962
[TBL] [Abstract][Full Text] [Related]
3. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer.
Radhakrishnan R; Kulhari H; Pooja D; Gudem S; Bhargava S; Shukla R; Sistla R
Chem Phys Lipids; 2016 Jun; 198():51-60. PubMed ID: 27234272
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation.
Fangueiro JF; Andreani T; Fernandes L; Garcia ML; Egea MA; Silva AM; Souto EB
Colloids Surf B Biointerfaces; 2014 Nov; 123():452-60. PubMed ID: 25303852
[TBL] [Abstract][Full Text] [Related]
5. Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers.
Hajipour H; Hamishehkar H; Nazari Soltan Ahmad S; Barghi S; Maroufi NF; Taheri RA
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):283-292. PubMed ID: 29310467
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic, toxicokinetic, and bioavailability studies of epigallocatechin-3-gallate loaded solid lipid nanoparticle in rat model.
Ramesh N; Mandal AKA
Drug Dev Ind Pharm; 2019 Sep; 45(9):1506-1514. PubMed ID: 31215261
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin-3-gallate encapsulated realgar nanoparticles exhibit enhanced anticancer therapeutic efficacy against acute promyelocytic leukemia.
Fang W; Peng ZL; Dai YJ; Wang DL; Huang P; Huang HP
Drug Deliv; 2019 Dec; 26(1):1058-1067. PubMed ID: 31735064
[TBL] [Abstract][Full Text] [Related]
8. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
Doktorovova S; Souto EB; Silva AM
Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial Activity of Epigallocatechin-3-gallate (EGCG) Loaded Lipid-chitosan Hybrid Nanoparticle against Planktonic Microorganisms.
Moreno APD; Marcato PD; Silva LB; Salvador SLS; Arco MCGD; Moraes JCB; Silva RSD; Rossi A
J Oleo Sci; 2024; 73(5):709-716. PubMed ID: 38692893
[TBL] [Abstract][Full Text] [Related]
10. Cellular uptake and cytotoxicity of chitosan-caseinophosphopeptides nanocomplexes loaded with epigallocatechin gallate.
Hu B; Ting Y; Zeng X; Huang Q
Carbohydr Polym; 2012 Jun; 89(2):362-70. PubMed ID: 24750731
[TBL] [Abstract][Full Text] [Related]
11. Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies.
Fangueiro JF; Calpena AC; Clares B; Andreani T; Egea MA; Veiga FJ; Garcia ML; Silva AM; Souto EB
Int J Pharm; 2016 Apr; 502(1-2):161-9. PubMed ID: 26921515
[TBL] [Abstract][Full Text] [Related]
12. Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation.
Frias I; Neves AR; Pinheiro M; Reis S
Drug Des Devel Ther; 2016; 10():3519-3528. PubMed ID: 27826184
[TBL] [Abstract][Full Text] [Related]
13. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
Kazi J; Sen R; Ganguly S; Jha T; Ganguly S; Chatterjee Debnath M
Int J Pharm; 2020 Jul; 585():119449. PubMed ID: 32464231
[TBL] [Abstract][Full Text] [Related]
14. Design, characterization and in vitro evaluation of linalool-loaded solid lipid nanoparticles as potent tool in cancer therapy.
Rodenak-Kladniew B; Islan GA; de Bravo MG; Durán N; Castro GR
Colloids Surf B Biointerfaces; 2017 Jun; 154():123-132. PubMed ID: 28334689
[TBL] [Abstract][Full Text] [Related]
15. Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy.
Sanna V; Singh CK; Jashari R; Adhami VM; Chamcheu JC; Rady I; Sechi M; Mukhtar H; Siddiqui IA
Sci Rep; 2017 Feb; 7():41573. PubMed ID: 28145499
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796
[TBL] [Abstract][Full Text] [Related]
17. Cationic solid lipid nanoparticles interfere with the activity of antioxidant enzymes in hepatocellular carcinoma cells.
Doktorovová S; Santos DL; Costa I; Andreani T; Souto EB; Silva AM
Int J Pharm; 2014 Aug; 471(1-2):18-27. PubMed ID: 24836663
[TBL] [Abstract][Full Text] [Related]
18. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
19. Production of monodisperse epigallocatechin gallate (EGCG) microparticles by spray drying for high antioxidant activity retention.
Fu N; Zhou Z; Jones TB; Tan TT; Wu WD; Lin SX; Chen XD; Chan PP
Int J Pharm; 2011 Jul; 413(1-2):155-66. PubMed ID: 21554936
[TBL] [Abstract][Full Text] [Related]
20. Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer.
Tang P; Sun Q; Yang H; Tang B; Pu H; Li H
Int J Pharm; 2018 Jul; 545(1-2):74-83. PubMed ID: 29715531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
